BlackRock Inc. - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 30 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$262,451
-15.5%
101,725
+41.5%
0.00%
Q2 2023$310,673
+183.3%
71,915
+0.3%
0.00%
Q1 2023$109,655
-0.8%
71,670
+2.5%
0.00%
Q4 2022$110,508
+30.0%
69,937
+1.5%
0.00%
Q3 2022$85,000
-37.0%
68,870
+3.2%
0.00%
Q2 2022$135,000
-4.3%
66,717
+18.2%
0.00%
Q1 2022$141,000
-35.6%
56,439
-3.6%
0.00%
Q4 2021$219,000
-2.7%
58,572
+4.6%
0.00%
Q3 2021$225,000
-17.6%
55,970
-8.6%
0.00%
Q2 2021$273,000
-50.5%
61,259
+1.8%
0.00%
Q1 2021$551,000
-2.7%
60,165
+7.9%
0.00%
Q4 2020$566,000
+205.9%
55,781
+27.4%
0.00%
Q3 2020$185,000
-40.1%
43,773
-1.7%
0.00%
Q2 2020$309,000
+186.1%
44,508
+16.0%
0.00%
Q1 2020$108,000
-30.8%
38,373
+19.7%
0.00%
Q4 2019$156,000
+194.3%
32,053
+25.1%
0.00%
Q3 2019$53,000
-60.4%
25,612
-5.4%
0.00%
Q2 2019$134,000
+185.1%
27,075
+159.7%
0.00%
Q1 2019$47,00010,4240.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 419,942$1,869,0000.98%
Manatuck Hill Partners, LLC 570,500$2,539,0000.77%
Corriente Advisors, LLC 203,641$906,0000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 275,000$1,224,0000.40%
Ikarian Capital, LLC 415,000$1,847,0000.15%
COOPERMAN LEON G 50,000$223,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 46,562$207,0000.01%
Trexquant Investment LP 17,019$76,0000.01%
TWO SIGMA SECURITIES, LLC 30,511$136,0000.00%
MARSHALL WACE, LLP 155,662$693,0000.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders